BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37170739)

  • 1. [Not Available].
    Petersen CL; Bergmann TK
    Ugeskr Laeger; 2023 May; 185(19):. PubMed ID: 37170739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review.
    Curtis KM; Nanda K; Kapp N
    AIDS; 2009 Nov; 23 Suppl 1():S55-67. PubMed ID: 20081389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women.
    Iversen L; Fielding S; Lidegaard Ø; Hannaford PC
    Contraception; 2020 Sep; 102(3):152-158. PubMed ID: 32592798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contraception and carcinogenic risks].
    Cappelaere P
    Lille Med; 1971; 16():45-51. PubMed ID: 4926823
    [No Abstract]   [Full Text] [Related]  

  • 7. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
    N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contraception and cancer: CNGOF Contraception Guidelines].
    Pragout D; Laurence V; Baffet H; Raccah-Tebeka B; Rousset-Jablonski C
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):834-844. PubMed ID: 30385358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
    Tang JH; Lopez LM; Mody S; Grimes DA
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009805. PubMed ID: 23152281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and hormonal contraception: an overview and a clinician's practical guide.
    Cipriani S; Todisco T; Scavello I; Di Stasi V; Maseroli E; Vignozzi L
    Eat Weight Disord; 2020 Oct; 25(5):1129-1140. PubMed ID: 31515745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
    Krashin J; Tang JH; Mody S; Lopez LM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intrauterine device and the intrauterine system.
    Stephen Searle E
    Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):807-24. PubMed ID: 24947600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postpartum hormonal contraception in breastfeeding women.
    Stanton TA; Blumenthal PD
    Curr Opin Obstet Gynecol; 2019 Dec; 31(6):441-446. PubMed ID: 31436540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy.
    Melbostad HS; Wachtel DS; Lipke KA; Badger GJ; Matusiewicz AK; Rey CN; MacAfee LK; Dougherty AK; Heil SH
    Contraception; 2022 Jun; 110():16-20. PubMed ID: 35283082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal contraception use before and after breast cancer diagnosis: A nationwide drug utilization study.
    Mørch LS; Friis S; Meaidi A; Dehlendorff C; Skovlund CW; Duun-Henriksen AK
    Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):706-709. PubMed ID: 35320606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraception use and attitudes: women's concerns regarding hormonal contraception and copper intrauterine devices.
    Svahn S; Niemeyer Hultstrand J; Tydén T; Ekstrand Ragnar M
    Eur J Contracept Reprod Health Care; 2021 Dec; 26(6):473-478. PubMed ID: 34590968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraception for women over 40].
    Erny R; Mathet M
    Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of contraception on gynecologic cancers.
    Herbst AL; Berek JS
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1980-5. PubMed ID: 8512041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.